AlgenScribe

Nice, France

Algenscribe develops genome editing tools for gene therapy and bioproduction.

$541K raised

Nov 2025

Seed

Top Investors

YES invest

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AlgenScribe raised?

AlgenScribe has raised $541K in total funding. The most recent round was Seed. The last funding was announced in November 2025.

Who are AlgenScribe's investors?

AlgenScribe's investors include YES invest.

Where is AlgenScribe headquartered?

AlgenScribe is headquartered in Nice, France.

What does AlgenScribe do?

Algenscribe develops genome editing tools for gene therapy and bioproduction.

What stage is AlgenScribe at?

AlgenScribe is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 21, 2025.

MLA

"AlgenScribe — Funding & Investors." VCBacked, November 21, 2025, https://www.vcbacked.co/company/algenscribe. Accessed June 17, 2026.

APA

VCBacked. (2025). AlgenScribe — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/algenscribe

Wikipedia (cite web)

{{cite web |title=AlgenScribe — Funding & Investors |url=https://www.vcbacked.co/company/algenscribe |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 21, 2025.